November 28, 2023
The Japanese government on November 28 granted approval to Meiji Seika Pharma’s COVID-19 vaccine Kostaive and an updated version of Daiichi Sankyo’s jab Daichirona targeting the XBB Omicron subvariant of the novel coronavirus. Both are mRNA vaccines. Previously known as...read more